ZA200709481B - Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV - Google Patents

Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV

Info

Publication number
ZA200709481B
ZA200709481B ZA200709481A ZA200709481A ZA200709481B ZA 200709481 B ZA200709481 B ZA 200709481B ZA 200709481 A ZA200709481 A ZA 200709481A ZA 200709481 A ZA200709481 A ZA 200709481A ZA 200709481 B ZA200709481 B ZA 200709481B
Authority
ZA
South Africa
Prior art keywords
azapurines
deazapurines
reverse transcriptase
hiv
transcriptase inhibitors
Prior art date
Application number
ZA200709481A
Inventor
Girardet Jean Luc
Shaw Stephanie
Koh Yung-Hyo
Kim Hong Woo
Original Assignee
Ardea Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardea Biosciences Inc filed Critical Ardea Biosciences Inc
Publication of ZA200709481B publication Critical patent/ZA200709481B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine

Abstract

This application concerns certain 2-phenylamino-6-aryl amino-, 6-aryloxy-, and 6-arylthio-purines, -azapurines and -deazapurines. These compounds are non-nucleoside reverse transcriptase inhibitors and have potential as anti-HIV treatment.
ZA200709481A 2005-05-05 2007-11-02 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV ZA200709481B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67866705P 2005-05-05 2005-05-05

Publications (1)

Publication Number Publication Date
ZA200709481B true ZA200709481B (en) 2008-11-26

Family

ID=37397195

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200709481A ZA200709481B (en) 2005-05-05 2007-11-02 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV

Country Status (12)

Country Link
US (2) US8227601B2 (en)
EP (1) EP1877411B9 (en)
JP (2) JP5138585B2 (en)
CN (1) CN101233135B (en)
AT (1) ATE541848T1 (en)
AU (1) AU2006244195B2 (en)
BR (1) BRPI0611455A2 (en)
CA (1) CA2607021C (en)
ES (1) ES2380951T3 (en)
MX (1) MX2007013715A (en)
WO (1) WO2006122003A2 (en)
ZA (1) ZA200709481B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100475815C (en) * 2003-09-25 2009-04-08 詹森药业有限公司 HIV-reproduction-inhibitive purinderivater
EP1877411B9 (en) 2005-05-05 2012-08-29 Ardea Biosciences, Inc. Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
CN101611035A (en) * 2006-12-28 2009-12-23 大正制药株式会社 Pyrazolopyrimidine compound
WO2009079412A2 (en) 2007-12-14 2009-06-25 Ardea Biosciences Inc. Reverse transcriptase inhibitors
EA017952B1 (en) 2008-02-06 2013-04-30 Новартис Аг PYRROLO[2,3-d]PYRIDINES AND USE THEREOF AS TYROSINE KINASE INHIBITORS
WO2010111406A2 (en) * 2009-03-24 2010-09-30 Myriad Pharmaceuticals, Inc. Compounds and therapeutic uses thereof
WO2014207082A1 (en) * 2013-06-27 2014-12-31 Janssen R&D Ireland Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
SG11201607990QA (en) 2014-04-25 2016-11-29 Pfizer Heteroaromatic compounds and their use as dopamine d1 ligands
EP3778605A3 (en) 2015-02-13 2021-03-10 Dana Farber Cancer Institute, Inc. Lrrk2 inhibitors and methods of making and using the same
CN106188060A (en) * 2015-04-29 2016-12-07 厦门大学 Pyrimido azoles, its preparation method, Pharmaceutical composition and application thereof
KR102048719B1 (en) * 2015-08-13 2019-11-26 베이징 한미 파마슈티컬 컴퍼니 리미티드 IRAK4 inhibitors and uses thereof
CN106117242B (en) * 2016-06-27 2018-08-03 山东大学 Tetrahydric thiapyran miazines derivative and the preparation method and application thereof
CN107793417B (en) * 2016-09-05 2020-06-09 复旦大学 Pyrrolo [2,3-d ] pyrimidines and salts thereof, preparation method and medicinal application
CN106749266B (en) * 2016-11-14 2019-01-22 山东大学 The high efficiency preparation method of pyrrolo- [2,3-d] pyrimidines
TW201945003A (en) 2018-03-01 2019-12-01 愛爾蘭商健生科學愛爾蘭無限公司 2,4-diaminoquinazoline derivatives and medical uses thereof
CN111499639B (en) * 2019-01-31 2022-03-04 四川大学华西医院 Pyrimidone derivatives and their use in pharmacy
WO2022011171A1 (en) * 2020-07-08 2022-01-13 Klotho Therapeutics, Inc. Novel compounds and methods for increasing klotho gene expression

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
WO2000027850A2 (en) 1998-11-12 2000-05-18 Neurocrine Biosciences, Inc. Crf receptor antagonists and methods relating thereto
US6414147B1 (en) 1998-12-23 2002-07-02 Neurogen Corporation 2-amino-9-alkylpurines: GABA brain receptor ligands
CZ27399A3 (en) 1999-01-26 2000-08-16 Ústav Experimentální Botaniky Av Čr Substituted nitrogen heterocyclic derivatives process of their preparation, the derivatives employed as medicaments, pharmaceutical composition and a compound pharmaceutical preparation in which these derivatives are comprised as well as use of these derivatives for preparing medicaments
YU25500A (en) 1999-05-11 2003-08-29 Pfizer Products Inc. Process for the synthesis of nucleosite analogues
JO3429B1 (en) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv Hiv inhibiting pyrimidines derivatives
CA2513527C (en) 2003-02-07 2012-08-14 Janssen Pharmaceutica N.V. Pyrimidine derivatives for the prevention of hiv infection
CN100475815C (en) * 2003-09-25 2009-04-08 詹森药业有限公司 HIV-reproduction-inhibitive purinderivater
CA2577588C (en) 2004-10-29 2013-09-10 Tibotec Pharmaceuticals Ltd. Hiv inhibiting bicyclic pyrimidine derivatives
EP1877411B9 (en) 2005-05-05 2012-08-29 Ardea Biosciences, Inc. Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv

Also Published As

Publication number Publication date
BRPI0611455A2 (en) 2010-09-08
ATE541848T1 (en) 2012-02-15
US8354532B2 (en) 2013-01-15
EP1877411A2 (en) 2008-01-16
ES2380951T9 (en) 2012-12-21
JP2008540454A (en) 2008-11-20
ES2380951T3 (en) 2012-05-21
MX2007013715A (en) 2008-01-28
CA2607021A1 (en) 2006-11-16
JP5138585B2 (en) 2013-02-06
US20120226037A1 (en) 2012-09-06
AU2006244195B2 (en) 2012-03-15
CA2607021C (en) 2013-10-29
EP1877411B1 (en) 2012-01-18
WO2006122003A2 (en) 2006-11-16
CN101233135A (en) 2008-07-30
US8227601B2 (en) 2012-07-24
JP2012188454A (en) 2012-10-04
CN101233135B (en) 2012-10-03
EP1877411A4 (en) 2008-10-22
AU2006244195A1 (en) 2006-11-16
US20090124802A1 (en) 2009-05-14
EP1877411B9 (en) 2012-08-29
WO2006122003A3 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
ZA200709481B (en) Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV
MX2009013349A (en) Chemical compounds.
MX2009009292A (en) Ppar active compounds.
EA201000777A1 (en) Inhibitors of Human Immunodeficiency Virus Replication
TW200603783A (en) Non-nucleoside reverse transcriptase inhibitors
MX2009005009A (en) 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors.
MX2009009290A (en) Ppar active compounds.
TW201713640A (en) Bruton's tyrosine kinase inhibitors
EA201390609A1 (en) HIDANTOIN DERIVATIVES USEFUL AS KV3-CHANNEL INHIBITORS
TW200626068A (en) Active compounds for seed treatment
NO20055130L (en) Aminocyclohexyl ether compounds and their use
MX2009006536A (en) Organic compounds and their uses.
ATE518010T1 (en) ACTIVE SURFACE COUPLED POLYMERASES
MX2009005881A (en) Non-nucleoside reverse transcriptase inhibitors.
MY163477A (en) Pyrimidinyl-pyridazinone derivatives
MX2010006738A (en) Hcv protease inhibitors and uses thereof.
MX2010006736A (en) Hcv protease inhibitors and uses thereof.
MX2009009761A (en) Compositions and kits for treating influenza.
MX2009008347A (en) Oxabicycloheptanes and oxabicycloheptenes, their preparation and use.
WO2009079412A3 (en) Reverse transcriptase inhibitors
ZA200802848B (en) Potassium channel inhibitors
TNSN08400A1 (en) Organic compounds and their uses
EA200971068A1 (en) TRIAZOLYLAMINOPYRIMIDINE COMPOUNDS
TW200716088A (en) Formulations and methods for treating amyloidosis
TW200738700A (en) HIV integrase inhibitors